Hepatitis B virus (HBV) infects the liver and can cause chronic infection, liver cirrhosis, and liver cancer. In most high-income countries, hepatitis B is rare. In the Philippines, it is endemic — meaning it circulates continuously at high levels in the population. Understanding this disease is not just medical knowledge; it is a matter of life and death for millions of Filipino families.
Why Hepatitis B Matters in the Philippines
The Philippines has one of the highest hepatitis B burdens in Asia. Prevalence estimates consistently place the infection rate between 12% and 16% of the adult population — meaning roughly 1 in 7 Filipinos is chronically infected with HBV.
This high prevalence is largely explained by two factors: widespread mother-to-child transmission before universal birth dose vaccination programs, and a historically low rate of testing and awareness. Many of the adults infected today were infected at birth or in early childhood — before they could make any choice about it.
How It Spreads
Hepatitis B is not spread through casual contact. You cannot get HBV from sharing food, hugging, coughing, or using the same bathroom as an infected person. It is spread through contact with infected blood and bodily fluids. The most common routes of transmission in the Philippines include:
- Mother to child at birth (perinatal transmission): The most common route of chronic infection in the Philippines. An infected mother can pass the virus to her newborn during delivery. This is why the birth dose vaccine within 24 hours is critical.
- Unprotected sexual contact: HBV is 50–100 times more infectious than HIV when transmitted sexually.
- Sharing needles or syringes: Including tattoo needles, piercings, or other skin-piercing equipment that is not properly sterilized.
- Blood transfusion or medical procedures: Rare in modern healthcare settings with proper screening, but a historical route of transmission.
- Shared personal items: Razors or toothbrushes that may carry traces of blood.
Most Filipinos Don't Know They Have It
This is the central challenge of hepatitis B in the Philippines: the virus is largely silent. Chronic HBV infection produces no symptoms in the vast majority of people for years or even decades — while quietly damaging the liver. By the time symptoms appear, the disease may have progressed to cirrhosis or liver cancer.
Because many infected Filipinos feel perfectly healthy, they do not seek testing. They do not know to protect their partners. They do not receive monitoring or treatment that could prevent liver damage. This is why widespread testing — making HBsAg testing a routine part of annual checkups — is one of the most impactful public health interventions available.
Symptoms
Acute Hepatitis B
When first infected, most adults (70%) have no symptoms. Some develop an acute illness within 1–4 months of infection that may include:
- Fatigue and general malaise
- Loss of appetite and nausea
- Abdominal pain (upper right, where the liver sits)
- Dark urine and pale stools
- Jaundice (yellowing of the skin and eyes)
- Joint pain
Most adults with acute HBV clear the virus within 6 months. A small percentage — especially those infected as adults — develop chronic infection.
Chronic Hepatitis B
When HBV infection lasts more than 6 months, it becomes chronic. The liver enzyme levels may be normal, and the person may feel well — sometimes for decades. Over time, however, chronic HBV can cause progressive liver scarring (fibrosis), cirrhosis, liver failure, and liver cancer. Symptoms of advanced liver disease include: fatigue, jaundice, abdominal swelling, easy bruising, and confusion (in late-stage disease).
Testing
A small blood sample is all that is needed to test for hepatitis B. The most important tests are:
| Test | What It Detects | Purpose |
|---|---|---|
| HBsAg (Hepatitis B Surface Antigen) | Whether the virus is currently present in the body | Screening — positive = infected or recently vaccinated (transient) |
| Anti-HBs (Hepatitis B Surface Antibody) | Protective antibodies from vaccination or past infection | Confirms immunity — positive = protected |
| Anti-HBc (Hepatitis B Core Antibody) | Past or present infection with HBV | Helps distinguish past infection from vaccination |
| HBV DNA (Viral Load) | Amount of virus currently in the blood | Used to guide treatment decisions and monitor response to therapy |
| HBeAg / Anti-HBe | Virus replication activity | Indicates how actively the virus is replicating; guides treatment |
| Liver Enzymes (ALT, AST) | Liver inflammation | Assesses current liver damage; monitored regularly |
Who should be tested: All adults who have not been tested should undergo HBsAg testing. Priority groups include pregnant women (to prevent mother-to-child transmission), household contacts and sexual partners of HBV-infected individuals, healthcare workers, and people born in or with parents from endemic regions (including the Philippines).
Vaccination
Hepatitis B vaccination is safe, highly effective, and one of the most important tools for ending the HBV epidemic in the Philippines. The vaccine is available at Chong Hua Hospital and at public health centers nationwide.
The Birth Dose — Critical for Breaking the Cycle
The most important dose is the birth dose — administered within 24 hours of delivery. This single dose, when given promptly, reduces the risk of mother-to-child transmission of HBV by up to 90%. Despite being part of the national immunization program, birth dose coverage in the Philippines has been inconsistent — particularly in home births and rural areas. Parents should specifically ask their birth attendant or midwife to ensure the hepatitis B birth dose is given.
Standard Vaccination Schedule
The standard 3-dose series (at birth, 1–2 months, and 6 months) provides long-lasting protection for infants. Unvaccinated adults and adolescents can still be vaccinated — 3 doses over 6 months provide over 90% protection. Some accelerated schedules (for those who need rapid protection) are also available.
Treatment
Not everyone with chronic hepatitis B requires antiviral treatment immediately. Treatment decisions are based on viral load (HBV DNA level), liver inflammation (ALT levels), degree of liver damage (assessed by biopsy or non-invasive tests like FibroScan), HBeAg status, and the patient's age and overall health.
Who Needs Treatment
Treatment is generally recommended for patients with:
- HBV DNA above threshold levels with active liver inflammation or fibrosis
- Cirrhosis, even with low viral load
- Family history of liver cancer
- Patients about to undergo immunosuppressive therapy
Current Medications
Antiviral medications for hepatitis B suppress viral replication, reducing liver damage, slowing fibrosis progression, and lowering the risk of liver cancer. They do not cure HBV, but they can put the infection into long-term remission. The preferred first-line treatments are:
- Tenofovir disoproxil fumarate (TDF): Highly effective, very low resistance rate; preferred for most patients. Also used in HIV treatment, providing benefit for co-infected patients.
- Entecavir: Also highly effective with a low resistance rate; an alternative first-line option, preferred in patients with kidney concerns.
- Tenofovir alafenamide (TAF): A newer form of tenofovir with improved kidney and bone safety; used in selected patients.
Treatment requires long-term commitment — often indefinitely — and regular monitoring of liver function, viral load, and kidney function.
The Liver Cancer Link
Hepatitis B is the leading cause of hepatocellular carcinoma (HCC) — the most common form of primary liver cancer — in the Philippines. HBV-related liver cancer often develops in people with cirrhosis, but it can also develop in chronic HBV carriers without cirrhosis, which makes surveillance particularly important for all chronically infected patients.
The risk of liver cancer in chronic HBV carriers is estimated to be 100 times higher than in uninfected individuals. HBV-related liver cancer is highly preventable through:
- Universal vaccination (prevents new HBV infections)
- Testing to identify infected individuals
- Antiviral treatment to suppress viral replication
- Regular liver cancer surveillance (ultrasound + AFP every 6 months) for high-risk patients
When to See a Doctor
You should discuss hepatitis B with your doctor if:
- You have never been tested for HBsAg and live in the Philippines
- You are pregnant or planning to become pregnant
- A family member has been diagnosed with hepatitis B
- You have had sexual contact with someone who may have HBV
- You have received a tattoo or piercing with non-sterile equipment
- You have been diagnosed with HBV and are not currently in regular follow-up
- You develop symptoms of liver disease: jaundice, abdominal swelling, persistent fatigue, or unexplained weight loss